Zivo Bioscience, Inc.
ZIVO
$15.00
-$2.00-11.77%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 53.40K | -- | 90.00K | 31.50K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 53.40K | -- | 90.00K | 31.50K | -- |
| Cost of Revenue | 35.50K | -- | 63.00K | 22.10K | -- |
| Gross Profit | 17.90K | -- | 27.00K | 9.50K | -- |
| SG&A Expenses | 1.17M | 1.44M | 1.38M | 1.94M | 5.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.69M | 4.21M | 1.69M | 2.29M | 8.23M |
| Operating Income | -1.63M | -4.21M | -1.60M | -2.26M | -8.23M |
| Income Before Tax | -1.64M | -4.21M | -1.60M | -2.27M | -8.24M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.64M | -4.21M | -1.60M | -2.27M | -8.24M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.64M | -4.21M | -1.60M | -2.27M | -8.24M |
| EBIT | -1.63M | -4.21M | -1.60M | -2.26M | -8.23M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.43 | -1.12 | -0.45 | -0.67 | -2.78 |
| Normalized Basic EPS | -0.27 | -0.70 | -0.28 | -0.42 | -1.74 |
| EPS Diluted | -0.43 | -1.12 | -0.45 | -0.67 | -2.78 |
| Normalized Diluted EPS | -0.27 | -0.70 | -0.28 | -0.42 | -1.74 |
| Average Basic Shares Outstanding | 3.81M | 3.75M | 3.54M | 3.41M | 2.96M |
| Average Diluted Shares Outstanding | 3.81M | 3.75M | 3.54M | 3.41M | 2.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |